iRhythm Technologies

Senior Director, Population Health and Value Innovation

United States

Not SpecifiedCompensation
Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Healthcare, Medical Devices, BiotechnologyIndustries

About iRhythm

Employment Type: Full time

Career-defining. Life-changing. At iRhythm, you’ll have the opportunity to grow your skills and your career while impacting the lives of people around the world. iRhythm is shaping a future where everyone, everywhere can access the best possible cardiac health solutions. Every day, we collaborate, create, and constantly reimagine what’s possible. We think big and move fast, driven by our commitment to put patients first and improve lives. We need builders like you. Curious and innovative problem solvers looking for the chance to meaningfully shape the future of cardiac health, our company, and your career.

About This Role

The Senior Director, Global Value Access and Value Innovation is a senior strategic leader responsible for defining, articulating, and delivering the clinical, economic, and technological value of iRhythm’s solutions—most notably the Zio platform—to payers, providers, policymakers, and health systems. In this role, you will be accountable for leading the integration of health economics and outcomes research (HEOR), market access strategy, real-world evidence, and AI innovation to drive broader adoption and optimized reimbursement. You will focus on designing and deploying scalable Population Health Programs that expand the Total Addressable Market (TAM) and meet the evolving needs of at-risk healthcare organizations. Additionally, you will be responsible for creating field-deployable programmatic plays that empower Market Access and Commercial teams to deliver tailored solutions to health systems, integrated networks, and payer partners in alignment with value-based care (VBC) goals.

What You Will Be Doing

1. Strategy Development

  • Lead the development of integrated value-based strategies that combine HEOR, AI innovation, and payer policy insights to support lifecycle management and commercialization success.
  • Shape iRhythm’s roadmap for AI-enabled diagnostics and predictive modeling in alignment with market access, clinical, and operational goals.
  • Translate healthcare policy trends and payer dynamics—especially for cardiovascular comorbid populations—into actionable growth strategies.

2. Population Health Program Development & TAM Expansion

  • Design and oversee the launch of scalable Population Health Programs that use predictive models, risk stratification, and targeted monitoring pathways to identify and manage high-need populations (e.g., diabetes, CKD, COPD).
  • Ensure these programs are integrated into health system workflows and value-based care arrangements, enabling earlier intervention, improved outcomes, and cost savings.
  • Drive TAM growth by identifying new patient segments and clinical scenarios where Zio monitoring delivers clinical and economic value.

3. Programmatic Play Creation and Field Enablement

  • Develop and institutionalize programmatic plays that can be operationalized by Market Access and Commercial teams across diverse customer types.
  • Provide strategic blueprints, messaging frameworks, and outcome-based models that field teams can adapt to payer/provider needs.
  • Collaborate with Sales Training and Commercial Operations to ensure materials are accessible, measurable, and scalable.

4. Evidence Generation & Real-World Research

  • Lead development of real-world evidence (RWE) and economic data that reinforce the clinical and economic value of iRhythm’s technologies.
  • Partner with Clinical Development and Medical Affairs to ensure endpoints support both regulatory requirements and health system decision-making.
  • Guide creation of payer value dossiers, HTA submissions, and peer-reviewed publications that support access, reimbursement, and guideline inclusion.

5. Innovation and AI Integration

  • Direct iRhythm’s AI strategy from a payer and provider utility lens, ensuring that innovations in prediction and workflow support are clinically relevant and economically compelling.
  • Align predictive modeling outputs with operational programs and value-based payment models.
  • Support the integration of AI to

Skills

Population Health
Value Innovation
Health Economics and Outcomes Research (HEOR)
Market Access Strategy
Real-World Evidence
AI Innovation
Value-Based Care (VBC)
Payer Policy
Commercialization
Predictive Modeling
Strategic Leadership

iRhythm Technologies

Advanced cardiac monitoring solutions provider

About iRhythm Technologies

iRhythm Technologies focuses on cardiac monitoring solutions, with its main product being the Zio Patch, a wearable device that tracks heart rhythms for up to 14 days. This extended monitoring helps healthcare providers detect irregular heart rhythms that shorter monitoring might miss, making it especially useful for patients at risk. The company serves both patients and healthcare providers, generating revenue by selling the Zio Patch and offering data analysis services to interpret the collected heart data. iRhythm aims to improve patient outcomes and streamline healthcare workflows in the cardiac health sector.

San Francisco, CaliforniaHeadquarters
2006Year Founded
$102.8MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
1,001-5,000Employees

Benefits

Health Insurance
Dental Insurance
Vision Insurance
Health Savings Account/Flexible Spending Account
Unlimited Paid Time Off
Paid Vacation
Paid Holidays
401(k) Retirement Plan
401(k) Company Match
Employee Stock Purchase Plan
Mental Health Support
Hybrid Work Options
Pet Insurance

Risks

Increased competition from emerging cardiac monitoring technologies threatens market share.
FDA warning letter may lead to regulatory scrutiny and potential fines.
Shareholder investigation could result in legal challenges and financial liabilities.

Differentiation

Zio Patch offers up to 14 days of uninterrupted cardiac monitoring.
iRhythm's Zio Patch is the smallest and least conspicuous cardiac diagnostic device.
The company provides data analysis services for actionable insights from Zio Patch data.

Upsides

Wearable health tech market growth aligns with iRhythm's business model.
Telehealth expansion increases demand for remote monitoring solutions like Zio Patch.
AI integration enhances arrhythmia detection accuracy in iRhythm's Zio Patch.

Land your dream remote job 3x faster with AI